Back
Apellis Pharmaceuticals Vs. Argan Industry Stock Comparison
Sell
36
APLS
Apellis Pharmaceuticals
Last Price:
$18.38
Seasonality Move:
-14.59%
Buy
67
AGX
Argan
Last Price:
$215.64
Seasonality Move:
1.53%
Sell
36
Apellis Pharmaceuticals (APLS)
is a Sell
Is Apellis Pharmaceuticals a Buy, Sell or Hold?
-
The current Apellis Pharmaceuticals [APLS] share price is $18.39. The Score for APLS is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
-
APLS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
APLS Stock Price Chart
What is Apellis Pharmaceuticals's stock price today?
-
The Apellis Pharmaceuticals share price today is $18.39The current trend is relatively stagnant and APLS is experiencing slight buying pressure.
AGX Stock Price Chart
APLS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.08 | Sell |
Relative Strength Index (14 RSI): | 49.98 | Sell |
Chaikin Money Flow: | 222297 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (17.42 - 19.1) | Buy |
Bollinger Bands (100): | (17.53 - 26.03) | Sell |
AGX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 6.1 | Buy |
Relative Strength Index (14 RSI): | 52.39 | Buy |
Chaikin Money Flow: | -190566 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (200.96 - 223.9) | Sell |
Bollinger Bands (100): | (123.57 - 194.61) | Buy |
APLS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 18.12 | Buy |
20-day SMA: | 18.42 | Sell |
50-day SMA: | 18.2 | Buy |
200-day SMA: | 26.52 | Sell |
8-day EMA: | 18.26 | Buy |
20-day EMA: | 18.33 | Buy |
50-day EMA: | 19.12 | Sell |
200-day EMA: | 26.71 | Sell |
AGX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 211.42 | Sell |
20-day SMA: | 215.85 | Sell |
50-day SMA: | 186.31 | Buy |
200-day SMA: | 145.65 | Buy |
8-day EMA: | 211.67 | Sell |
20-day EMA: | 209.66 | Sell |
50-day EMA: | 191.01 | Buy |
200-day EMA: | 146.76 | Buy |
Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.11 per share, an increase next quarter of $0.19 per share, a decrease this year of $0.13 per share, and an increase next year of $1.13 per share.
Argan Earnings Growth & AGX Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.44 per share, an increase next quarter of $0.35 per share, an increase this year of $2.73 per share, and an increase next year of $1.51 per share.
Apellis Pharmaceuticals Technical Analysis
Jun 11 | Jun 12 | Jun 13 | Jun 16 | Jun 17 | Jun 18 | Jun 20 | Jun 23 | Jun 24 | Jun 25 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
11 | 12 | 13 | 16 | 17 | 18 | 20 | 23 | 24 | 25 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Argan Technical Analysis
Jun 11 | Jun 12 | Jun 13 | Jun 16 | Jun 17 | Jun 18 | Jun 20 | Jun 23 | Jun 24 | Jun 25 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
11 | 12 | 13 | 16 | 17 | 18 | 20 | 23 | 24 | 25 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |